Veterinary Parasiticides Market Overview
The Veterinary Parasiticides Market was valued at USD 4.1 Billion in 2024 and is expected to grow from USD 4.2 Billion in 2025 to USD 5.8 Billion by 2035, registering a CAGR of 3.2% during the forecast period from 2026 to 2035. Market growth is being supported by increasing pet ownership, rising veterinary expenditure, growing awareness of animal health, concerns surrounding zoonotic diseases, and advances in parasiticide formulations and delivery systems.
Veterinary parasiticides are used to protect animals from parasites that can affect health, productivity, and quality of life. The market includes endoparasiticides, ectoparasiticides, combination products, and anthelmintics. Products are available in different formulations and administration routes to meet the needs of companion animals and livestock.
Increasing pet ownership is creating sustained demand for parasite-prevention products. Pet owners are increasingly focused on preventive healthcare, regular veterinary visits, and products that provide convenient and effective parasite protection.
Technological advances are also influencing the market. Long-lasting formulations, combination products, and improved delivery systems are being developed to increase convenience and treatment adherence. Research into parasite resistance is creating additional demand for new product approaches.
North America holds a significant market share because of high pet ownership rates, veterinary expenditure, and established regulatory frameworks. Asia Pacific is emerging as a rapidly growing market due to increasing pet adoption, rising disposable incomes, and growing awareness of animal healthcare.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=637371
Key Companies in the Global Veterinary Parasiticides Market
Noah’s Animal Hospitals
Zoetis
Dechra Pharmaceuticals
Boehringer Ingelheim
Vetoquinol
PetIQ
Virbac
Bayer Animal Health
Elanco
Merck Animal Health
Elanco Animal Health
Ceva Santé Animale
Patterson Companies
Merial
Kemin Animal Nutrition
Heska Corporation
Market Dynamics and Growth Drivers
The increasing pet population is a major factor supporting demand for veterinary parasiticides. As more households own companion animals and spend more on preventive healthcare, demand for regular parasite control is increasing.
Livestock health represents another important application area. Parasites can affect animal productivity and welfare, making parasite management an important part of livestock-health programs.
Growing awareness of zoonotic diseases is also influencing the market. Some parasites can have implications for both animal and human health, increasing interest in prevention and veterinary intervention.
Product innovation is creating additional opportunities. Long-lasting treatments can reduce the frequency of administration, while combination products can address multiple parasite categories. Oral and topical formulations are gaining attention because of their convenience and ease of administration.
Regional Market Insights
North America holds a significant share of the market due to high pet ownership, strong veterinary infrastructure, and established animal-health regulations. Europe also represents an important market with substantial veterinary expenditure and awareness of animal welfare.
Asia Pacific is projected to experience notable growth as pet adoption rises and disposable incomes increase. South America and the Middle East and Africa represent emerging markets where expanding veterinary services and greater awareness of parasitic diseases can support demand.
Market Segmentation
By type, the market includes Endoparasiticides, Ectoparasiticides, Combination Products, and Anthelmintics.
By animal type, the market covers Pets, Livestock, Aquaculture, and Horses. Pet demand is expected to increase significantly as companion-animal ownership and preventive healthcare spending rise.
By formulation, the market includes Liquid, Powder, Injectable, and Tablet formulations.
By route of administration, the market is segmented into Oral, Topical, and Injectable products. Oral and topical formulations are gaining traction because of their convenience and potential to improve treatment compliance.
Recent Developments and Market Trends:
Zoetis announced a collaboration with Noah’s Animal Hospitals in March 2025 to pilot a parasite-prevention program supported by digital health tools and adherence analytics.
Elanco announced a major contract with Patterson Companies in May 2025 to distribute its parasiticide portfolio across North American veterinary clinics.
Virbac launched a broad-spectrum parasiticide product for dogs and cats in June 2025, expanding its portfolio and addressing parasite-resistance concerns.
Long-lasting parasiticide formulations are gaining attention for their convenience.
Combination products are being developed to provide broader parasite protection.
Growing awareness of zoonotic diseases is supporting preventive parasite-management programs.
Veterinary telemedicine is creating new opportunities for animal-health consultation and treatment monitoring.
Reasons to Buy the Report:
Understand the projected development of the Veterinary Parasiticides Market through 2035.
Analyze the market by type, animal type, formulation, route of administration, and region.
Evaluate the influence of pet ownership, livestock health, and zoonotic disease awareness.
Review major companies and recent developments in veterinary parasiticides.
Assess opportunities associated with long-lasting products, combination therapies, telemedicine, and emerging markets.
Future Outlook:
The Veterinary Parasiticides Market is expected to grow steadily through 2035 as pet ownership, livestock production, preventive animal healthcare, and awareness of parasitic diseases increase. Product development is likely to focus on long-lasting formulations, combination products, improved delivery systems, and approaches to parasite resistance. Expanding veterinary services and rising disposable incomes in Asia Pacific and other emerging markets may further support long-term demand.
➤➤Explore Our Latest Related Reports:
